Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Fallopian Tube Neoplasms × Immunoglobulin G × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Alveolar Soft Part 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Brenner Tumor 1

Interventions

Paclitaxel 3 mirvetuximab soravtansine 2 Bevacizumab 2 rucaparib 1 pembrolizumab 1 liposomal doxorubicin 1 Topotecan 1 Taxes 1 Saline Solution 1 Immunoglobulin G 1 Glucose 1 Docetaxel 1 Disulfides 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00262847 2019-07-23

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

National Cancer Institute (NCI)

Phase 3 Completed

1,873 enrolled 17 charts 1 FDA

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡